Europe recommends seven new medicines for approval

Europe recommended seven new drugs for approval on Friday, including two antibiotics for skin infections and a new treatment option for HIV. Regulator European Medicines Agency gave the green light to The Medicines Company’s oritavancin and Cubist Pharmaceuticals tedizolid phosphate for the treatment of acute bacterial skin and skin structure infections. The Medicines Company’s drug cangrelor for the reduction of thrombotic cardiovascular events was also recommended for approval, as was its Raplixa, a fibrinogen and thrombin powder, for improvement of haemostasis.
Sexual Health News Headlines – Yahoo! News